Patents by Inventor Kurt Bachmaier

Kurt Bachmaier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CBLB for treating endotoxin-mediated disorders
    Patent number: 8168176
    Abstract: Methods of treating endotoxin-mediated disorders are provided.
    Type: Grant
    Filed: November 12, 2007
    Date of Patent: May 1, 2012
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: Kurt Bachmaier, Asrar B. Malik
  • CBLB for Treating Endotoxin-Mediated Disorders
    Publication number: 20100061970
    Abstract: Methods of treating endotoxin-mediated disorders are provided.
    Type: Application
    Filed: November 12, 2007
    Publication date: March 11, 2010
    Applicant: The Board of Trustees of the University of Illinois
    Inventors: Kurt Bachmaier, Asrar B. Malik
  • Nucleic acids encoding myocardial peptides
    Patent number: 6034230
    Abstract: Disclosed are novel peptides that modulate inflammatory heart disease. Also disclosed are DNA molecules encoding the peptides, and methods of making the peptides.
    Type: Grant
    Filed: May 3, 1999
    Date of Patent: March 7, 2000
    Assignee: Amgen Canada Inc.
    Inventors: Kurt Bachmaier, Andrew John Hessel, Nickolaus Neu, Josef Martin Penninger
  • Peptides capable of modulating inflammatory heart disease
    Patent number: 5962636
    Abstract: Disclosed are novel peptides that modulate inflammatory heart disease. Also disclosed are DNA molecules encoding the peptides, and methods of making the peptides.
    Type: Grant
    Filed: August 12, 1998
    Date of Patent: October 5, 1999
    Assignee: Amgen Canada Inc.
    Inventors: Kurt Bachmaier, Andrew John Hessel, Nickolaus Neu, Josef Martin Penninger